Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NY/Rochester
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Rochester, NY

Studies commonly pay $75 to $4,500 per completed study

459 clinical trials are currently recruiting participants within 30 miles of Rochester. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

459studies recruiting
8+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Rochester right now

Top 25 of 459 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Acute Leukemia, Lymphoblastic Leukemia Phase 1, Phase 2 Interventional 15 participants sought
University of Rochester Medical Center, Wilmot Cancer Center — Rochester, New York (0.9 mi) · Sponsor: University of Chicago
See eligibility & contact on ClinicalTrials.gov (NCT06207123)

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis, Crohn's Disease Phase 3 Interventional 240 participants sought
University of Rochester Medical Center - PPDS — Rochester, New York (0.9 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT05442567)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Rochester, New York (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP

HoLEP, Patient Satisfaction N/A Interventional 114 participants sought
University of Rochester Medical Center — Rochester, New York (0.9 mi) · Sponsor: University of California, San Francisco
See eligibility & contact on ClinicalTrials.gov (NCT06975033)

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Barrett Esophagus, Barretts Esophagus With Dysplasia N/A Interventional 2,298 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: University of Colorado, Denver
See eligibility & contact on ClinicalTrials.gov (NCT05530343)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Skin Search of Rochester — Rochester, New York (0.9 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Breast Neoplasms Phase 3 Interventional 558 participants sought
Rochester General Hospital Lipson Cancer Institute — Rochester, New York (0.9 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT07173751)

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma Phase 3 Interventional 720 participants sought
Research Site — Rochester, New York (0.9 mi) · Sponsor: Arcus Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07011719)

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

Alcohol Use Disorder, Retinal Dystrophies Phase 1 Interventional 15 participants sought
Flaum Eye Institute, University of Rochester Medical Center — Rochester, New York (0.9 mi) · Sponsor: University of Rochester
See eligibility & contact on ClinicalTrials.gov (NCT06319872)

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Cardiovascular, Metabolic Disease Phase 1 Interventional 90 participants sought
Research Site 21 — Rochester, New York (0.9 mi) · Sponsor: CRISPR Therapeutics AG
See eligibility & contact on ClinicalTrials.gov (NCT07491172)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Rochester General Hospital — Rochester, New York (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Chronic Low-back Pain, Vertebrogenic Pain Syndrome N/A Observational 1,500 participants sought
University of Rochester — Rochester, New York (0.9 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06827262)

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Bladder Cancer N/A Observational 900 participants sought
University of Rochester Medical Center — Rochester, New York (0.9 mi) · Sponsor: Cedars-Sinai Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT03193541)
Google-rated

Top-rated research centers in Rochester

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Rochester Clinical Research, LLC

★ 4.7
500 Helendale Rd, Rochester, NY 14609
(585) 288-0890
"All the staff members are professional, efficient and kind.The nurses are easy to connect with. Great experience!"
— Denise Derrick, 5★

Clinical Research Center

500 Helendale Rd, Rochester, NY 14609
(585) 288-0890

Clinical Translational Science Institute

★ 5.0
265 Crittenden Blvd, Rochester, NY 14642
(585) 275-2107
"Super nice people. We're working on the building and their staff has been very professional to work with."
— Eric Bracken, 5★

LDM Clinical Research Source

425 East Ridge Road Box 17221, Rochester, NY 14621
(585) 654-8878

Clinical Research Institute, University

601 Elmwood Ave, Rochester, NY 14642

Clinical Trials

601 Elmwood Ave, Rochester, NY 14642

UR Medicine Saunders Research Building

265 Crittenden Blvd, Rochester, NY 14620
(585) 275-2107

Center For Clinical Research

Rochester, NY 14623
(585) 273-2518

Clinical trials in Rochester: what's recruiting

The Rochester area currently has 459 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Rochester, the most active research areas are:

  • Cancer & Oncology13 studies
  • Immune & Skin3 studies
  • Liver & Kidney1 studies
  • Heart & Vascular1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Rochester, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Rochester

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Rochester participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Rochester pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Rochester?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Rochester?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Rochester?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Rochester.

Paid clinical trials near Rochester

Other metros within reach

Buffalo, NY520 Syracuse, NY256 Binghamton, NY18 Scranton, PA100 Erie, PA91 Harrisburg, PA412 Reading, PA281 York, PA459

More of NY

Staten Island4,243 Brooklyn4,241 New York4,179 Manhattan4,173 Bronx4,155 Queens4,142 Yonkers4,130 Buffalo520 Syracuse256 Albany192 Poughkeepsie73

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts